Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Liabilities and Shareholders Equity: 2015-2022

Historic Liabilities and Shareholders Equity for HUTCHMED (China) (HCM) over the last 8 years, with Dec 2022 value amounting to $1.0 billion.

  • HUTCHMED (China)'s Liabilities and Shareholders Equity rose 40.85% to $1.8 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $5.4 billion, marking a year-over-year increase of 12.16%. This contributed to the annual value of $1.0 billion for FY2022, which is 25.00% down from last year.
  • HUTCHMED (China)'s Liabilities and Shareholders Equity amounted to $1.0 billion in FY2022, which was down 25.00% from $1.4 billion recorded in FY2021.
  • In the past 5 years, HUTCHMED (China)'s Liabilities and Shareholders Equity registered a high of $1.4 billion during FY2021, and its lowest value of $465.1 million during FY2019.
  • Over the past 3 years, HUTCHMED (China)'s median Liabilities and Shareholders Equity value was $1.0 billion (recorded in 2022), while the average stood at $1.0 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 89.56% in 2021, then fell by 25.00% in 2022.
  • Over the past 5 years, HUTCHMED (China)'s Liabilities and Shareholders Equity (Yearly) stood at $532.1 million in 2018, then decreased by 12.59% to $465.1 million in 2019, then spiked by 55.68% to $724.1 million in 2020, then surged by 89.56% to $1.4 billion in 2021, then dropped by 25.00% to $1.0 billion in 2022.